focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.025
Bid: 1.00
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.05 (5.00%)
Open: 1.025
High: 1.025
Low: 1.025
Prev. Close: 1.025
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

End of Formal Sale Process

22 Dec 2020 07:00

RNS Number : 4424J
Microsaic Systems plc
22 December 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7OF THE REGULATION (EU) NO 596/2014 ON MARKET ABUSE

 

22 December 2020

 

Microsaic Systems plc

("Microsaic" or the "Company")

End of Formal Sale Process

Appointment of KRE Corporate Recovery Limited

Microsaic Systems plc (AIM: MSYS), regrets to announce that its formal sale process has concluded without securing any definitive offer for the Company or any other solution which would provide sufficient funding for the Company to pursue its business plans. As a result, the Company has appointed KRE Corporate Recovery Limited ("KRE") to explore other remaining options to maximise value for creditors and potentially other stakeholders.

As announced on 29 July 2020, following a market sounding exercise carried out in the middle of 2020, the Board had concluded that the prevailing conditions were not supportive at that time of raising sufficient equity from public market investors to fund the business through to profitability. The Board, had, therefore, appointed BDO LLP as its financial adviser, with regards to a Strategic Review, including a formal sale process for the purposes of Rule 3 of the City Code on Takeovers and Mergers (the "Takeover Code").

Since then, a very extensive process has been undertaken with outbound and inbound approaches to and from a large number of parties. From discussions with multiple potentially interested parties during the formal sale process, it became clear that their key considerations included the effect of the Covid-19 pandemic on their own businesses, the future investment required to take the Microsaic business to positive cash generation, and the continuing uncertainty around forward trading assumptions due to the ongoing impact of the pandemic. Following the cessation of discussions with the last remaining interested party, the formal sale process has regrettably now concluded without securing any definitive offer for the shares of the Company or for any other solution which would provide sufficient funding for the Company to pursue its business plans.

The interim results announcement on 2 September 2020 included the following statement on going concern:

"In view of the inherent uncertainties implicit in a Strategic Review process, there is a material uncertainty related to going concern. If the Strategic Review does not result in an appropriate outcome, the Directors would have to consider other actions for protecting stakeholders' interests."

In the light of the outcome of the formal sale process, the Board has now considered what actions are appropriate to protect stakeholders' interests. In particular, the Board has taken advice on the best way of maximising value for creditors and potentially other stakeholders and has, therefore, appointed KRE to run a process to offer the business and assets of the Company for sale. This process is expected to run until around the end of January 2021 and, based on facts presently known, the Board believes that the Company has sufficient cash to make essential, ongoing payments falling due during this period. Contact details for KRE are included below and any potentially interested parties are encouraged to contact KRE at the earliest possible opportunity.

At this time, no party has been identified which is prepared to make an offer for the Company, or its business and assets and there can be no certainty that any transaction will be concluded, nor as to the terms on which any form of transaction would be made. A sale of the business and assets might involve an administration process.

It is possible (but not certain) that a sale of the Company's business and assets may be effected following the appointment of an administrator. In the event that KRE identifies that the sale of the Company's business and assets is unlikely to generate incremental value for creditors or other stakeholders, the Board would have to initiate steps to appoint a liquidator to wind-up the Company's affairs. Any appointment of an administrator or liquidator would be likely to trigger immediate suspension of the Company's shares from admission to trading on AIM. In addition, if the Company were to go into administration or liquidation, additional costs would be incurred and liabilities may accelerate or crystallise which would diminish the potential realisations for stakeholders.

Following this announcement, the Company is no longer considered to be in an "offer period" as defined in the Takeover Code.

 

For further information, please contact:

Microsaic Systems plc

+44 (0) 1483 751 577

Glenn Tracey, CEO

Bevan Metcalf, FD

 

N+1 Singer (Nominated Adviser & Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

KRE Corporate Recovery Ltd

Gareth Roberts, Director (gareth.roberts@krecr.co.uk)

David Taylor, Director (david.taylor@krecr.co.uk)

+44 (0) 7979 706 392

+44 (0) 7855 231 103

 

 

Important notices

This announcement contains inside information for the purposes of Article 7 of the Regulation (EU) No 596/2014 on Market Abuse. Upon the publication of this announcement, this information is considered to be in the public domain.

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFEAESFESSELE
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.